Lupin Limited (LUPIN) Share Analysis
NSE · Healthcare · Pharmaceuticals
Lupin Limited (NSE: LUPIN) is an Indian listed company in the Pharmaceuticals sector and a constituent of NIFTY 200, NIFTY 500, NIFTY Healthcare Index. As of 21 Sep 2026, the share price was ₹2,083.00, market capitalisation ₹95,248 Cr, P/E 16, ROE 28.7%.
Get the AI verdict on LUPIN: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
Stored fundamentals as of 21 Sep 2026 — not a live quote. Signed-in analysis uses same-day data.
LUPIN price and valuation
- Share price
- ₹2,083.00
- Market cap
- ₹95,248 Cr
- P/E ratio
- 16
- P/B ratio
- 4.24
- EPS
- ₹120.98
- Book value per share
- ₹491.00
- Dividend yield
- 0.86%
LUPIN profitability and growth
- ROE
- 28.7%
- ROCE
- 29.9%
- Debt to equity
- 0.29
- Revenue growth (3 yr)
- 19%
- Revenue growth (5 yr)
- 13%
- Profit growth (3 yr)
- 140%
- Profit growth (5 yr)
- 37%
LUPIN 52-week range
- 52-week high
- ₹2,529.50
- 52-week low
- ₹1,900.00
- Face value
- ₹2.00
LUPIN shareholding pattern
- Promoters
- 46.85%
- FIIs
- 22.42%
- DIIs
- 24.65%
- Public
- 6.08%
Index membership: NIFTY 200, NIFTY 500, NIFTY Healthcare Index, NIFTY Midcap 100, NIFTY Midcap 150, NIFTY Midcap 50, NIFTY MidSmallcap 400, NIFTY Pharma, NIFTY Quality 30.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.